Evidence map›Paper›PMID 32023468›Full record

ArticleCell reports2020

Inverse Data-Driven Modeling and Multiomics Analysis Reveals Phgdh as a Metabolic Checkpoint of Macrophage Polarization and Proliferation.

Jayne Louise Wilson, Thomas Nägele, Monika Linke, Florian Demel, Stephanie D Fritsch, Hannah Katharina Mayr, Zhengnan Cai, Karl Katholnig, Xiaoliang Sun, Lena Fragner and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 94 citations in OpenAlex.

  1. Trial
  2. Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Jayne Louise WilsonCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria.
Thomas NägeleDepartment of Ecogenomics and Systems Biology, University of Vienna, Vienna 1090, Austria; Vienna Metabolomics Center (VIME), University of Vienna, Vienna 1090, Austria; Department Biology I, Ludwig Maximilians University Munich, 82152 Planegg-Martinsried, Germany.
Monika LinkeCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria.
Florian DemelCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria.
Stephanie D FritschCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria.
Hannah Katharina MayrCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria.
Zhengnan CaiDepartment of Ecogenomics and Systems Biology, University of Vienna, Vienna 1090, Austria.
Karl KatholnigCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria.
Xiaoliang SunVienna Metabolomics Center (VIME), University of Vienna, Vienna 1090, Austria.
Lena FragnerDepartment of Ecogenomics and Systems Biology, University of Vienna, Vienna 1090, Austria; Vienna Metabolomics Center (VIME), University of Vienna, Vienna 1090, Austria.
Anne MillerDepartment of Laboratory Medicine, Medical University of Vienna, Vienna 1090, Austria.
Arvand HaschemiDepartment of Laboratory Medicine, Medical University of Vienna, Vienna 1090, Austria.
Alexandra PopaCeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna 1090, Austria.
Andreas BergthalerCeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna 1090, Austria.
Markus HengstschlägerCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria.
Thomas WeichhartCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna 1090, Austria. Electronic address: thomas.weichhart@meduniwien.ac.at.
Wolfram WeckwerthDepartment of Ecogenomics and Systems Biology, University of Vienna, Vienna 1090, Austria; Vienna Metabolomics Center (VIME), University of Vienna, Vienna 1090, Austria. Electronic address: wolfram.weckwerth@univie.ac.at.
Medical University of Vienna · ATUniversity of Vienna · ATAustrian Academy of Sciences · ATCeMM Research Center for Molecular Medicine · AT

Funding

Austrian Science Fund FWF P 27701Austrian Science Fund FWF P 30857
6 · The paper itself

Abstract

Mechanistic or mammalian target of rapamycin complex 1 (mTORC1) is an important regulator of effector functions, proliferation, and cellular metabolism in macrophages. The biochemical processes that are controlled by mTORC1 are still being defined. Here, we demonstrate that integrative multiomics in conjunction with a data-driven inverse modeling approach, termed COVRECON, identifies a biochemical node that influences overall metabolic profiles and reactions of mTORC1-dependent macrophage metabolism. Using a combined approach of metabolomics, proteomics, mRNA expression analysis, and enzymatic activity measurements, we demonstrate that Tsc2, a negative regulator of mTORC1 signaling, critically influences the cellular activity of macrophages by regulating the enzyme phosphoglycerate dehydrogenase (Phgdh) in an mTORC1-dependent manner. More generally, while lipopolysaccharide (LPS)-stimulated macrophages repress Phgdh activity, IL-4-stimulated macrophages increase the activity of the enzyme required for the expression of key anti-inflammatory molecules and macrophage proliferation. Thus, we identify Phgdh as a metabolic checkpoint of M2 macrophages.

Indexed as

Cell PolarityGenomicsModels, BiologicalAnimalsCell ProliferationGene Expression Regulation, EnzymologicGlutamic AcidGlycineInterleukin-4Ketoglutaric AcidsKineticsMacrophagesMechanistic Target of Rapamycin Complex 1Mice, Inbred C57BLPhosphoglycerate DehydrogenasePrincipal Component AnalysisGlutamic AcidGlycineInterleukin-4Ketoglutaric AcidsMechanistic Target of Rapamycin Complex 1Phosphoglycerate DehydrogenaseSerineTuberous Sclerosis Complex 2 Proteinbiochemical Jacobiancancermacrophage polarizationmacrophage proliferationmetabolic modelingmetabolomicsmTORPhgdhserine/glycine pathwayTsc2tumor-associated macrophages

Identifiers

PMID32023468
PMCPMC7003064
OpenAlexW3005150131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.